QUADRAMED CORP (QD) is a publicly traded company in the Unknown sector. Across all available filings, 5 corporate insiders have executed 99 transactions totaling $3.5M, demonstrating a bearish sentiment with -$3.4M in net insider flow. The most recent transaction on Jun 24, 2008 involved a sale of 9,320 shares valued at $93.3K.
No significant insider buying has been recorded for QD in the recent period.
No significant insider selling has been recorded for QD in the recent period.
Based on recent SEC filings, insider sentiment for QD is bearish with an Insider Alignment Score of 2/100 and a net flow of -$3.4M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at QUADRAMED CORP (QD) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 5 insiders are actively trading QD stock, having executed 99 transactions in the past 90 days. The most active insider is Lawrence P. English (Executive), who has made 67 transactions totaling $2.7M.
Get notified when executives and directors at QD file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jun 24, 2008 | M. Knott David | Executive | Sale | 9,320 | $10.01 | $93.3K | |
| Jun 24, 2008 | M. Knott David | Executive | Sale | 80,200 | $10.01 | $802.8K | Large |
| Nov 23, 2007 | R. Klein James | Executive | Sale | 19,800 | $2.11 | $41.8K | |
| Nov 21, 2007 | R. Klein James | Executive | Sale | 200 | $2.15 | $430 | |
| Aug 17, 2007 | R. Klein James | Executive | Sale | 15,000 | $2.48 | $37.2K | |
| Aug 14, 2007 | R. Klein James | Executive | Sale | 35,000 | $2.50 | $87.5K | |
| Aug 13, 2007 | B. Hagen Keith | Executive | Purchase | 2,100 | $2.38 | $5.0K | |
| Aug 13, 2007 | B. Hagen Keith | Executive | Purchase | 22,749 | $2.40 | $54.6K | |
| Aug 13, 2007 | B. Hagen Keith | Executive | Purchase | 151 | $2.37 | $358 | |
| Mar 30, 2007 | R. Milligan James | Executive | Option Exercise | 8,875 | $1.90 | $16.9K | |
| Mar 30, 2007 | R. Milligan James | Executive | Sale | 8,875 | $2.97 | $26.4K | |
| Mar 30, 2007 | R. Milligan James | Executive | Option Exercise | 100 | $1.90 | $190 | |
| Mar 30, 2007 | R. Milligan James | Executive | Option Exercise | 1,725 | $1.70 | $2.9K | |
| Mar 30, 2007 | R. Milligan James | Executive | Sale | 1,725 | $2.97 | $5.1K | |
| Mar 30, 2007 | R. Milligan James | Executive | Sale | 100 | $2.98 | $298 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 80 | $3.5M | 85.9% |
Disposition(D) | 1 | $348.8K | 8.6% |
Exercise(M) | 13 | $159.7K | 4.0% |
Purchase(P) | 3 | $60.0K | 1.5% |
Award(A) | 2 | $0 | 0.0% |
Insider selling pressure at QUADRAMED CORP has increased, with 5 insiders executing 99 transactions across all time. Total sales of $3.5M significantly outpace purchases of $60.0K, resulting in a net outflow of $3.4M. This selling activity appears largely discretionary, which may warrant closer attention from investors.